Search

for
Search:

Did you mean Protein Degradation?

Glossary Protein Degradation

process of breaking down proteins into amino acids

Protein degradation is the process by which cells break down proteins into their constituent amino acids. This is essential for regulating protein levels, removing damaged or misfolded proteins, and recycling amino acids for new protein synthesis. In the context of hair and alopecia, disruptions in protein degradation pathways can affect hair follicle health and contribute to hair loss.

Related Terms

Research

5 / 1000+ results

research Evolving CRBN ligands enhance the drug-like properties of protein degraders

July 2026 in “Journal of Enzyme Inhibition and Medicinal Chemistry”

This review discusses the evolution of Cereblon ligands in PROTAC technology, highlighting chemical innovations that may enhance drug-likeness and applicability in protein degradation, while noting challenges and future research directions.

research Clinical Translation of Targeted Protein Degraders

40 citations , July 2023 in “Clinical Pharmacology & Therapeutics”

This review discusses the progress and challenges of targeted protein degradation therapies, highlighting the increasing number of degraders in cancer clinical trials and the limited diversity in targeted proteins, primarily focusing on those employing CRL4^CRBN as the E3 ligase.

research NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders

45 citations , July 2025 in “Journal of Medicinal Chemistry”

This article discusses the development and clinical progress of PROTAC technology, particularly focusing on the New Drug Application for vepdegestrant, an estrogen receptor-targeting PROTAC, marking significant advancements in targeted protein degradation therapies.

research 1116 Novel androgen receptor degrader for androgenetic alopecia (AGA) application

April 2023 in “Journal of Investigative Dermatology”

In this study, a novel AR protein degrader was shown to reverse DHT-induced hair regrowth delay in a mouse model of androgenetic alopecia, with minimal circulation and potential side effects.

research 52243 AH-001: An Emerging Androgen Receptor Degrader Showing Therapeutic Potential in Addressing Androgenetic Alopecia (AGA)

September 2024 in “Journal of the American Academy of Dermatology”

In this study, a novel compound named AH-001 demonstrated effective androgen receptor protein degradation, reducing hair loss progression in a mouse model of androgenetic alopecia, with minimal systemic exposure and side effects, suggesting potential for safer treatment.

View more "protein degrader" in research →

Community Join

5 / 662 results

community AH-001 another topical AR degrader beside GT20029, completed Phase I

8 upvotes 10 months ago

AH-001 is a new topical treatment designed to degrade androgen receptors, targeting the root cause of androgenetic alopecia without the side effects of oral treatments like finasteride. It has shown a strong safety profile and good local tolerability in early trials.

community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

133 upvotes 2 years ago

The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

community Most Promising Future Hair Loss Treatments In 2026

83 upvotes 2 weeks ago

Promising hair loss treatments in 2026 include GT20029, a topical androgen receptor degrader, and VDPHL01, an extended-release oral minoxidil, both offering safer alternatives with fewer side effects. Other treatments like sublingual minoxidil, OND-1, JW0061, TDM-105795, and AMP-303 are also being explored.

community Do exosomes actually work to regrow hair?

9 upvotes 1 year ago

Microneedling with exosomes is being considered for hair regrowth, but concerns exist about their effectiveness and safety, especially since exosomes degrade quickly and lack FDA approval. The user is seeking alternatives for non-responders to minoxidil and dutasteride, as exosomes may not provide additional benefits.

community My Theory Of Androgenic Alopecia

16 upvotes 10 months ago

Hair loss is linked to cellular physiology and the IGF-1 to TGF-B1 ratio, not just androgen sensitivity. The theory lacks evidence, while finasteride and minoxidil are effective treatments.

View more "protein degrader" in community →

Learn

5 / 800 results

Experts

— no results

Try a deeper search in experts →

Clinics